Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS)
CNY 14.76
(1.86%)
CNY 14.76
(1.86%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.15 Billion CNY | -9.1% |
| 2022 | 2.45 Billion CNY | 61.18% |
| 2021 | 1.56 Billion CNY | -17.24% |
| 2020 | 1.85 Billion CNY | 26.42% |
| 2019 | 1.46 Billion CNY | 92.92% |
| 2018 | 669.89 Million CNY | -30.96% |
| 2017 | 1.12 Billion CNY | 26.4% |
| 2016 | 863.37 Million CNY | 10.63% |
| 2015 | 745.76 Million CNY | 55.73% |
| 2014 | 493.9 Million CNY | -12.79% |
| 2013 | 579.86 Million CNY | 9.09% |
| 2012 | 530.44 Million CNY | 41.31% |
| 2011 | 375.55 Million CNY | 76.61% |
| 2010 | 208.7 Million CNY | -16.71% |
| 2009 | 253.22 Million CNY | 0.65% |
| 2008 | 253.58 Million CNY | 0.29% |
| 2007 | 255.41 Million CNY | 32.07% |
| 2006 | 195.32 Million CNY | -4.45% |
| 2005 | 204.41 Million CNY | 12.3% |
| 2004 | 182.02 Million CNY | 34.37% |
| 2003 | 135.47 Million CNY | 56.4% |
| 2002 | 86.61 Million CNY | 34.41% |
| 2001 | 64.44 Million CNY | 16.36% |
| 2000 | 55.38 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 752.08 Million CNY | 30.32% |
| 2024 Q1 | 486.93 Million CNY | 50.52% |
| 2024 Q3 | 409.52 Million CNY | -52.99% |
| 2023 FY | - CNY | -9.1% |
| 2023 Q3 | 291.76 Million CNY | -41.01% |
| 2023 Q1 | 336.22 Million CNY | -35.86% |
| 2023 Q2 | 494.59 Million CNY | 47.1% |
| 2023 Q4 | 332.6 Million CNY | 14.0% |
| 2022 Q2 | 567.09 Million CNY | 119.84% |
| 2022 Q3 | 497 Million CNY | -12.36% |
| 2022 Q4 | 524.21 Million CNY | 5.47% |
| 2022 FY | - CNY | 61.18% |
| 2022 Q1 | 257.95 Million CNY | -22.94% |
| 2021 FY | - CNY | -17.24% |
| 2021 Q2 | 357.59 Million CNY | -2.45% |
| 2021 Q3 | -59.57 Million CNY | -116.66% |
| 2021 Q4 | 334.76 Million CNY | 661.94% |
| 2021 Q1 | 366.57 Million CNY | 66.71% |
| 2020 Q1 | 340.96 Million CNY | 35.25% |
| 2020 Q2 | 501.96 Million CNY | 47.22% |
| 2020 Q4 | 219.88 Million CNY | -39.99% |
| 2020 Q3 | 366.44 Million CNY | -27.0% |
| 2020 FY | - CNY | 26.42% |
| 2019 FY | - CNY | 92.92% |
| 2019 Q1 | 221.85 Million CNY | 375.87% |
| 2019 Q3 | 281.78 Million CNY | -17.07% |
| 2019 Q4 | 252.09 Million CNY | -10.54% |
| 2019 Q2 | 339.78 Million CNY | 53.16% |
| 2018 Q3 | 163.81 Million CNY | 59.4% |
| 2018 FY | - CNY | -30.96% |
| 2018 Q4 | -80.42 Million CNY | -149.09% |
| 2018 Q2 | 102.77 Million CNY | -58.59% |
| 2018 Q1 | 248.21 Million CNY | 44.97% |
| 2017 Q2 | 223.13 Million CNY | 60.91% |
| 2017 Q3 | 324.05 Million CNY | 45.23% |
| 2017 FY | - CNY | 26.4% |
| 2017 Q4 | 171.21 Million CNY | -47.17% |
| 2017 Q1 | 138.66 Million CNY | -42.39% |
| 2016 Q3 | 132.86 Million CNY | -16.8% |
| 2016 Q1 | 150.76 Million CNY | -29.89% |
| 2016 Q4 | 240.71 Million CNY | 81.18% |
| 2016 Q2 | 159.69 Million CNY | 5.93% |
| 2016 FY | - CNY | 10.63% |
| 2015 Q4 | 215.03 Million CNY | 122.14% |
| 2015 FY | - CNY | 55.73% |
| 2015 Q1 | 120.08 Million CNY | 33.3% |
| 2015 Q2 | 181.61 Million CNY | 51.25% |
| 2015 Q3 | 96.8 Million CNY | -46.7% |
| 2014 Q1 | 70.12 Million CNY | -42.02% |
| 2014 Q2 | 108.18 Million CNY | 54.29% |
| 2014 Q4 | 90.08 Million CNY | -10.11% |
| 2014 FY | - CNY | -12.79% |
| 2014 Q3 | 100.21 Million CNY | -7.37% |
| 2013 Q2 | 143.37 Million CNY | 7.37% |
| 2013 FY | - CNY | 9.09% |
| 2013 Q4 | 120.93 Million CNY | 183.59% |
| 2013 Q3 | 42.64 Million CNY | -70.26% |
| 2013 Q1 | 133.53 Million CNY | -15.74% |
| 2012 Q1 | 96.78 Million CNY | 369.72% |
| 2012 FY | - CNY | 41.31% |
| 2012 Q4 | 158.47 Million CNY | 120.27% |
| 2012 Q3 | 71.94 Million CNY | -39.24% |
| 2012 Q2 | 118.4 Million CNY | 22.33% |
| 2011 Q2 | 74.13 Million CNY | -29.14% |
| 2011 Q1 | 104.61 Million CNY | 102.57% |
| 2011 FY | - CNY | 76.61% |
| 2011 Q4 | 20.6 Million CNY | -75.84% |
| 2011 Q3 | 85.27 Million CNY | 15.02% |
| 2010 Q4 | 51.64 Million CNY | 89.36% |
| 2010 Q1 | 34.54 Million CNY | -45.3% |
| 2010 Q2 | 26.13 Million CNY | -24.35% |
| 2010 Q3 | 27.27 Million CNY | 4.37% |
| 2010 FY | - CNY | -16.71% |
| 2009 Q4 | 63.15 Million CNY | 64.55% |
| 2009 Q1 | 42.74 Million CNY | -21.57% |
| 2009 Q2 | 47.49 Million CNY | 11.12% |
| 2009 FY | - CNY | 0.65% |
| 2009 Q3 | 38.37 Million CNY | -19.19% |
| 2008 Q3 | 29.48 Million CNY | -60.87% |
| 2008 Q1 | 39.56 Million CNY | -23.36% |
| 2008 Q2 | 75.36 Million CNY | 90.5% |
| 2008 Q4 | 54.49 Million CNY | 84.8% |
| 2008 FY | - CNY | 0.29% |
| 2007 FY | - CNY | 32.07% |
| 2007 Q1 | 46.04 Million CNY | 2.96% |
| 2007 Q2 | 87.94 Million CNY | 90.98% |
| 2007 Q3 | 34.34 Million CNY | -60.94% |
| 2007 Q4 | 51.62 Million CNY | 50.3% |
| 2006 Q4 | 44.72 Million CNY | -5.71% |
| 2006 Q2 | 52.07 Million CNY | 3.49% |
| 2006 Q3 | 47.43 Million CNY | -8.91% |
| 2006 Q1 | 50.31 Million CNY | -23.13% |
| 2006 FY | - CNY | -4.45% |
| 2005 Q4 | 65.45 Million CNY | 100.15% |
| 2005 Q3 | 32.7 Million CNY | -51.56% |
| 2005 Q2 | 67.51 Million CNY | 32.57% |
| 2005 Q1 | 50.92 Million CNY | -2.08% |
| 2005 FY | - CNY | 12.3% |
| 2004 Q2 | 52.51 Million CNY | 41.13% |
| 2004 Q1 | 37.2 Million CNY | -21.3% |
| 2004 Q4 | 52 Million CNY | 8.32% |
| 2004 Q3 | 48.01 Million CNY | -8.57% |
| 2004 FY | - CNY | 34.37% |
| 2003 Q3 | 32.29 Million CNY | 4.96% |
| 2003 FY | - CNY | 56.4% |
| 2003 Q2 | 30.77 Million CNY | 15.93% |
| 2003 Q1 | 26.54 Million CNY | -1.35% |
| 2003 Q4 | 47.27 Million CNY | 46.38% |
| 2002 Q1 | 15.34 Million CNY | 0.0% |
| 2002 Q3 | 14.56 Million CNY | -28.67% |
| 2002 Q4 | 26.9 Million CNY | 84.72% |
| 2002 Q2 | 20.42 Million CNY | 33.1% |
| 2002 FY | - CNY | 34.41% |
| 2001 FY | - CNY | 16.36% |
| 2000 FY | - CNY | 0.0% |